Press Releases

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Nov. 8, 2019-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that the Company’s Board of Directors has appointed

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Oct. 31, 2019-- TransEnterix, Inc. (NYSEAmerican: TRXC) announced today that it plans to release third quarter financial and operating results after the market closes on Tuesday, November 12, 2019 . The Company will host a conference call to discuss

● Company’s action intended to increase the market price of its Common Stock in connection with its previously-announced pursuit of strategic alternatives ● Special Meeting of Stockholders to approve Reverse Stock Split scheduled for December 18, 2019 ● Preliminary Proxy Statement filed with the

- Received initial $3 million payment in connection with amended AutoLap transaction - One Senhance System sold in the third quarter - The Company has engaged J.P. Morgan to assist its Board of Directors in evaluating strategic alternatives to enhance stockholder value - Announces implementation of

Society of Laparoendoscopic Surgeons Recognizes Advanced Technology MORRISVILLE, N.C. --(BUSINESS WIRE)--Sep. 11, 2019-- TransEnterix, Inc. (NYSE American: TRXC) a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today

MORRISVILLE, N.C. --(BUSINESS WIRE)--Sep. 5, 2019-- TransEnterix, Inc. (NYSE American: TRXC) today announced that it priced a public offering of 28,000,000 shares of its common stock for gross proceeds of approximately $20.3 million , before deducting underwriting discounts and commissions and

MORRISVILLE, N.C. --(BUSINESS WIRE)--Sep. 4, 2019-- TransEnterix, Inc. (NYSE American: TRXC) today announced that it has commenced an underwritten public offering of shares of its common stock. TransEnterix intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Aug. 21, 2019-- TransEnterix, Inc. (NYSE American: TRXC) announced today that Todd M. Pope , President and Chief Executive Officer and Joseph P. Slattery , Executive Vice President and Chief Financial Officer, will present at the Wells Fargo

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Aug. 7, 2019-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the

Reimbursement decision provides expanded access to Senhance Digital Laparoscopy for patients, surgeons, and hospitals across Japan RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Aug. 1, 2019-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics